We are live on ! Find out more
AIM

Achmea Investment Management Portfolio holdings

AUM $4B
1-Year Est. Return 31.99%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
+31.99%
3 Year Est. Return
+113.82%
5 Year Est. Return
+148.81%
10 Year Est. Return
–
AUM
$2.83B
AUM Growth
-$267M
Cap. Flow
-$146M
Cap. Flow %
-5.17%
Top 10 Hldgs %
23.51%
Holding
675
New
40
Increased
132
Reduced
250
Closed
28

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$32.6M
2
WDAY icon
Workday
WDAY
+$17.9M
3
ADBE icon
Adobe
ADBE
+$10.1M
4
AMD icon
Advanced Micro Devices
AMD
+$7.37M
5
T icon
AT&T
T
+$7.28M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$16.6M
2
MSFT icon
Microsoft
MSFT
+$16M
3
TGT icon
Target
TGT
+$11.5M
4
TT icon
Trane Technologies
TT
+$10.3M
5
FERG icon
Ferguson
FERG
+$8.83M

Sector Composition

Rank Sector Weight
1 Technology 28.92%
2 Healthcare 18.36%
3 Financials 11.49%
4 Consumer Discretionary 10.21%
5 Industrials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTLT
601
DELISTED
CATALENT, INC.
CTLT
$22K ﹤0.01%
299
– –
ANSS
602
DELISTED
Ansys
ANSS
$21K ﹤0.01%
91
-1,986
-96% -$508K
ELS icon
603
Equity Lifestyle Properties
ELS
$12.4B
$21K ﹤0.01%
333
– –
LNC icon
604
Lincoln National
LNC
$8.4B
$21K ﹤0.01%
468
– –
PTC icon
605
PTC
PTC
$16.1B
$21K ﹤0.01%
200
– –
SBAC icon
606
SBA Communications
SBAC
$19.4B
$21K ﹤0.01%
71
-6,861
-99% -$2.23M
EVRG icon
607
Evergy
EVRG
$19.1B
$20K ﹤0.01%
331
– –
QSR icon
608
Restaurant Brands International
QSR
$25.8B
$20K ﹤0.01%
370
– –
BIO icon
609
Bio-Rad Laboratories Class A
BIO
$9.48B
$19K ﹤0.01%
44
-2,540
-98% -$1.27M
BMRN icon
610
BioMarin Pharmaceuticals
BMRN
$13.6B
$19K ﹤0.01%
221
– –
PPL
611
PPL Corp
PPL
$26.5B
$19K ﹤0.01%
744
– –
COIN icon
612
Coinbase
COIN
$39.1B
$18K ﹤0.01%
+272
New +$19K
FCNCA icon
613
First Citizens BancShares
FCNCA
$25.5B
$18K ﹤0.01%
+22
New +$17.2K
AVLR
614
DELISTED
Avalara, Inc.
AVLR
$18K ﹤0.01%
189
– –
ARMK icon
615
Aramark
ARMK
$16.1B
$17K ﹤0.01%
731
– –
RIVN icon
616
Rivian
RIVN
$23.1B
$17K ﹤0.01%
+512
New +$17.5K
ROST icon
617
Ross Stores
ROST
$79.9B
$17K ﹤0.01%
200
-18,205
-99% -$1.55M
ZEN
618
DELISTED
ZENDESK INC
ZEN
$17K ﹤0.01%
+217
New +$16.5K
AME icon
619
Ametek
AME
$59B
$16K ﹤0.01%
+140
New +$16.8K
BAX icon
620
Baxter International
BAX
$13.9B
$16K ﹤0.01%
283
-46,699
-99% -$2.81M
IP icon
621
International Paper
IP
$21.8B
$16K ﹤0.01%
490
-24,205
-98% -$989K
GRAB icon
622
Grab
GRAB
$14.8B
$15K ﹤0.01%
+5,588
New +$16.9K
RBLX icon
623
Roblox
RBLX
$25.3B
$15K ﹤0.01%
408
– –
RPM icon
624
RPM International
RPM
$14.7B
$15K ﹤0.01%
+181
New +$16.1K
APA icon
625
APA Corp
APA
$14.1B
$14K ﹤0.01%
392
– –
23 24
25
26 27

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return

Achmea Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Achmea Investment Management held 675 positions worth $2.83B, down 8.6% from $3.09B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Achmea Investment Management withdrew a net $146M in Q3 2022, closing 28 positions and reducing 250 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $7.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Achmea Investment Management opened a new position in AbbVie worth $30.5M.

  • Achmea Investment Management's largest Q3 2022 buy was AbbVie: 227,376 shares worth $30.5M.
  • Achmea Investment Management added most to Synopsys in Q3 2022, an estimated $5.91M increase.
  • Achmea Investment Management's biggest Q3 2022 reduction was Apple, cutting an estimated $16.6M.
  • Achmea Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q3 2022, selling an estimated $7.81M.
  • Achmea Investment Management's ten largest holdings make up 24% of its $2.83B portfolio in Q3 2022.
  • Achmea Investment Management opened 40 new positions and closed 28 in Q3 2022.
  • Achmea Investment Management's portfolio value fell 8.6% quarter-over-quarter to $2.83B.

Based on Achmea Investment Management's 13F filing for Q3 2022, filed 27 Oct 2022.